Check-Cap (MBAI) Net Income towards Common Stockholders Growth (5y) (2019 - 2024)
Check-Cap (MBAI) Net Income towards Common Stockholders Growth (5y) (2019 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Check-Cap | 8.04 Mn | 6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 50.18% |
| Dec 31, 2023 | -85.38% |
| Sep 30, 2023 | -0.85% |
| Jun 30, 2023 | -94.64% |
| Mar 31, 2023 | 17.94% |
| Dec 31, 2022 | 17.18% |
| Sep 30, 2022 | 14.80% |
| Jun 30, 2022 | -95.07% |
| Mar 31, 2022 | 17.30% |
| Dec 31, 2021 | 18.31% |
| Sep 30, 2021 | 19.31% |
| Jun 30, 2021 | -96.87% |
| Mar 31, 2021 | 5.40% |
| Dec 31, 2020 | 5.64% |
| Sep 30, 2020 | 137.38% |
| Jun 30, 2020 | -5.99% |
| Mar 31, 2020 | -3.55% |
| Dec 31, 2019 | 19.74% |
| Sep 30, 2019 | 64.36% |
| Jun 30, 2019 | 24.05% |